Biotech

All Articles

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has actually made an overdue entry to the radioligand event, paying out 100 thousand euros (...

F 2G increases $100M for 2nd attempt to receive brand-new antifungal to market

.After F2G's 1st try to get a brand-new lesson of antifungal to market was actually wrecked by the F...

Moderna targets $1.1 B in R&ampD costs slices, drops 5 programs among profits pressures

.Moderna has actually pledged to cut R&ampD costs by $1.1 billion by 2027. The choice to retract the...

Sanofi's $80M bank on Fulcrum dystrophy drug ends in phase 3 crash

.Just 4 months after Sanofi bet $80 thousand in upfront money on Fulcrum Therapeutics' losmapimod, t...

Oncternal equity sinks 60% in the middle of cutbacks, trial firings

.Cancer cells provider Oncternal Rehabs is folding all its professional tests and laying off workers...

Roche is actually holding out hopes that its own injectable excessive weight prospect can eventually demonstrate 25% fat loss in late-stage trial

.Roche is actually storing out hopes that its injectable weight problems prospect might inevitably d...

Novo Nordisk hails 'outstanding' fat loss result for dual-acting oral drug in early trial

.Novo Nordisk has elevated the cover on a stage 1 trial of its own oral amylin as well as GLP-1 rece...

AbbVie sues BeiGene over blood stream cancer medication secret method

.Merely a couple of brief full weeks after gaining an FDA Fast Track tag for its own investigational...

Lilly delivers one-two punch along with 2nd tranche of good data on weekly blood insulin prospect

.Soon after a positive information drop for Eli Lilly's efsitora alfa, the Indianapolis-based firm i...

BridgeBio cuts gene therapy finances as clinical information dissatisfy

.BridgeBio Pharma is lowering its genetics treatment budget and pulling back from the method after s...